Last updated: February 28, 2024
Sponsor: Northwestern University
Overall Status: Completed
Phase
N/A
Condition
Uterine Fibroids
Uterina Myoma
Dysfunctional Uterine Bleeding
Treatment
MyoSure Hysteroscopic Morcellator Device
Clinical Study ID
NCT04550429
STU00211845
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients electing for operative or diagnostic hysteroscopy procedures for managementof polyps and fibroids
- Age equal to or greater than 18
- Ability to understand and willingness to sign consent form. We will includenon-English speaking patients in this study
Exclusion
Exclusion Criteria:
- Patients electing for operative and diagnostic hysteroscopy procedures with polyps andfibroids
- Patients under the age of 18
Study Design
Total Participants: 35
Treatment Group(s): 1
Primary Treatment: MyoSure Hysteroscopic Morcellator Device
Phase:
Study Start date:
August 21, 2020
Estimated Completion Date:
September 11, 2023
Study Description
Connect with a study center
Center for Comprehensive Gynecology
Chicago, Illinois 60611
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.